chr12-110127388-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_014055.4(IFT81):āc.8A>Gā(p.Asp3Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000146 in 1,577,346 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. D3D) has been classified as Likely benign.
Frequency
Consequence
NM_014055.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFT81 | NM_014055.4 | c.8A>G | p.Asp3Gly | missense_variant | 2/19 | ENST00000242591.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFT81 | ENST00000242591.10 | c.8A>G | p.Asp3Gly | missense_variant | 2/19 | 1 | NM_014055.4 | P1 | |
IFT81 | ENST00000552912.5 | c.8A>G | p.Asp3Gly | missense_variant | 2/19 | 1 | P1 | ||
IFT81 | ENST00000361948.8 | c.8A>G | p.Asp3Gly | missense_variant | 2/12 | 1 | |||
IFT81 | ENST00000546374.5 | c.8A>G | p.Asp3Gly | missense_variant | 2/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152140Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000290 AC: 6AN: 206758Hom.: 0 AF XY: 0.0000267 AC XY: 3AN XY: 112190
GnomAD4 exome AF: 0.0000133 AC: 19AN: 1425206Hom.: 0 Cov.: 30 AF XY: 0.0000113 AC XY: 8AN XY: 707706
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152140Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74336
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2024 | The c.8A>G (p.D3G) alteration is located in exon 2 (coding exon 1) of the IFT81 gene. This alteration results from a A to G substitution at nucleotide position 8, causing the aspartic acid (D) at amino acid position 3 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 3 of the IFT81 protein (p.Asp3Gly). This variant is present in population databases (rs200581871, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with IFT81-related conditions. ClinVar contains an entry for this variant (Variation ID: 862599). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on IFT81 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at